Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Name Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)sort icon
Chlorpropamide Apo-chlorpropamide Antidiabetic agent 2017/02/01
Ivabradine Lancora Cardiac medication 2017/04
Insulin aspart + niacinamide Fiasp Insulin analogue 2017/04/06
Propiverine Mictoryl; Mictoryl Pediatric Anticholinergic and antispasmodic agent 2017/04/13
Brexpiprazole Rexulti Antipsychotic agent 2017/04/20
Eluxadoline Viberzi Miscellaneous GI drugs 2017/04/24
Eluxadoline Viberzi Miscellaneous GI drug 2017/05
Sarilumab Kevzara Disease modifying anti-rheumatic drug 2017/08/16
Glecaprevir + pibrentasvir Maviret Antiviral agent for treatment of chronic hepatitis C infection 2017/09/13
Sofosbuvir + velpatasvir + voxilaprevir Vosevi Antiviral agent for treatment of chronic hepatitis C infection 2017/09/18
Empagliflozin + metformin Synjardy Oral blood glucose lowering agents 2017/09/18
Cladribine Mavenclad Immunosuppressant 2017/11/30
Dupilumab Dupixent Skin and mucous membrane agent 2017/11/30
Palonosetron + netupitant Akynzeo Antiemetic 2017/12/04
Avelumab Bavencio Antineoplastic agent 2017/12/18
Letermovir Prevymis Antiviral agent 2017/12/20
Lifitegrast Xiidra Lymphocyte function associated antigen-1 (LFA-1) antagonist 2017/12/22
Migalastat Galafold Various alimentary tract and metabolism products 2018/01/15
Buprenorphine Belbuca Opioid analgesic 2018/01/17
Naltrexone + bupropion Contrave Anorexigenic agents 2018/02/13
Semaglutide Ozempic Incretin mimetic 2018/02/22
Flibanserin ADDYI CNS agent 2018/02/27
Saxagliptin + dapagliflozin Qtern Oral antihyperglycemic agent 2018/03/20
Ceftobiprole Zevtera Cephalosporin antibiotic 2018/03/20
Benralizumab Fasenra Respiratory agent 2018/03/28
Ixekizumab Taltz Immunomodulator 2018/03/29
Glycopyrrolate Cuvposa Antimuscarinic antispasmodic agent 2018/04/03
Buprenorphine Probuphine Opiate partial agonist 2018/04/18
Apomorphine Movapo Nonergot-derivative dopamine receptor agonist 2018/04/xx
Ertugliflozin + sitagliptin Steglujan Oral blood glucose lowering agents 2018/05/22
Ertugliflozin Steglatro Sodium-glucose co-transporter 2 (SGLT2) inhibitor 2018/05/23
Benzocaine Orajel teething products 2018/05/23
Ertugliflozin + metformin Segluromet Oral blood glucose lowering agents 2018/05/30
Liraglutide + Insulin Degludec Xultophy Incretin mimetic + insulin 2018/06/06
Iron isomaltoside Monoferric Iron preparation 2018/06/22
Ivacaftor + tezacaftor Symdeko Cystic Fibrosis Transmembrane Conductance Regulator Correctors and Potentiators 2018/06/27
Syndicate content